Indole derivatives regulate bone homeostasis via gut-bone axis in osteoporosisIndole derivatives may help manage bone health in osteoporosis
Frontiers in MedicinePublished August 21, 2026DOI ↗Editorial oversight: Dr. Lars van Dijk, PhD · Surgical, Procedural & Diagnostic
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Consider indole derivatives as a promising but unproven avenue for osteoporosis therapy via the gut-bone axis.
This systematic review examines the role of indole derivatives in osteoporosis, focusing on the gut-bone axis. The review synthesizes evidence from preclinical and mechanistic studies, though specific study details such as population, sample size, and comparators are not reported.
The key finding is that indole derivatives can regulate bone homeostasis through the gut-bone axis. The proposed mechanisms include modulation of gut microbiota composition, enhancement of intestinal barrier integrity, regulation of immune-inflammatory responses, and involvement of signaling pathways. These effects are thought to contribute to bone homeostasis.
The review aims to provide a theoretical basis for clinical application of indole derivatives in osteoporosis treatment and for the development of novel targeted drugs. However, the authors caution against overstating clinical application and treatment efficacy, as the evidence is largely mechanistic and preclinical.
Limitations are not reported in the source, and the certainty of evidence is not reported. The review does not provide quantitative effect sizes or safety data. Therefore, the findings should be interpreted as hypothesis-generating rather than definitive.
For clinicians, this review highlights a potential avenue for future osteoporosis therapies, but it does not support immediate clinical use. Further research, including clinical trials, is needed to establish efficacy and safety.
How this fits prior evidence
This systematic review extends prior coverage on gut microbiota interventions and osteoporosis by identifying indole derivatives as a specific class of compounds that may modulate bone metabolism through the gut-bone axis. It complements earlier findings that gut microbiota interventions may influence bone metabolism via immune and endocrine pathways. The review also aligns with the growing interest in bone quality assessment and risk stratification, as it focuses on mechanistic pathways rather than diagnostic or risk factors. However, unlike circRNAs or curcumin, which have quantitative evidence (AUC 0.91 and increased femoral bone density, respectively), this review lacks pooled effect sizes, so its contribution is primarily conceptual.
Living with osteoporosis means dealing with bones that become fragile and prone to breaking. While many treatments exist, researchers are looking closer at how our internal systems, like the gut, influence bone strength. This review explores a specific group of compounds called indole derivatives to see if they can help.
The research suggests these compounds might regulate bone homeostasis. This means they could help maintain a healthy balance in bone health by working through the gut-bone axis. By looking at things like gut bacteria and how the body handles inflammation, researchers hope to find a new way to target bone issues.
Because this is a theoretical review of mechanisms rather than a clinical trial on patients, we do not yet know how well these compounds work as a treatment in real life. The goal is to provide a foundation for creating new drugs that specifically target the link between gut health and bone strength.
What this means for you:
Indole derivatives may help balance bone health by improving the connection between the gut and the bones.
Common questions
What are indole derivatives?
Indole derivatives are a group of compounds that researchers believe can regulate bone homeostasis. This means they may help maintain a healthy balance in your bones by working through the gut-bone axis, which is the connection between your digestive system and your skeletal health.
Can these compounds treat osteoporosis?
This review provides a theoretical basis for using indole derivatives to treat osteoporosis. While they show promise in research regarding bone homeostasis and gut health, more study is needed to determine their actual effectiveness as a clinical treatment for patients.
Osteoporosis is a systemic skeletal disease characterized by low bone mass, deterioration of bone microarchitecture, and increased fracture risk, which imposes a heavy burden on global public health, especially in postmenopausal women and the elderly. The gut-bone axis, a bidirectional regulatory network between the gut microbiota and bone metabolism, has emerged as a novel therapeutic target for osteoporosis. Indole derivatives, a class of bioactive compounds derived from tryptophan metabolism by gut microbiota or plant secondary metabolism, have attracted increasing attention due to their extensive biological activities, including anti-inflammatory, antioxidant, and metabolic regulatory effects. Accumulating evidence indicates that indole derivatives can regulate bone homeostasis through the gut-bone axis, providing a new strategy for the prevention and treatment of osteoporosis. This review systematically summarizes the types of indole derivative, elaborates their molecular mechanisms in the treatment of osteoporosis via the gut-bone axis (including regulating gut microbiota composition, maintaining intestinal barrier integrity, modulating immune-inflammatory responses, and mediating key signaling pathways), and discusses the current translational progress, existing challenges, and future prospects. This review aims to provide a comprehensive theoretical basis for the clinical application of indole derivatives in osteoporosis treatment and the development of novel targeted drugs.
